AVIR

AVIR Operating Expenses

$145.27MTTM · USD

Period ending:

AVIR FY Operating ExpensesUSD
AVIR FY Operating Expenses2018-12-31: $9.48M2019-12-31: $14.61M2020-12-31: $21.64M2021-12-31: $45.79M2022-12-31: $68.26M2023-12-31: $94.07M2024-12-31: $109.58M2025-12-31: $180.89M$180.89M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVIR operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Atea Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
180,887,000
109,583,000
94,072,000
68,260,000
45,785,000
21,640,000
14,608,000
9,477,000

Compare operating expenses

All AVIR financial metrics · AVIR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.